These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 34656181)
1. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis. Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
4. The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis. Sobczak M; Pawliczak R Clin Mol Allergy; 2022 Jan; 20(1):1. PubMed ID: 35039051 [TBL] [Abstract][Full Text] [Related]
5. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
6. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis. Alhumaid S; Al Mutair A; Alali J; Al Dossary N; Albattat SH; Al HajjiMohammed SM; Almuaiweed FS; AlZaid MR; Alomran MJ; Alqurini ZS; Alsultan AA; Alhajji TS; Alshaikhnasir SM; Al Motared A; Al Mutared KM; Hajissa K; Rabaan AA Diseases; 2022 Dec; 10(4):. PubMed ID: 36547204 [TBL] [Abstract][Full Text] [Related]
8. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551 [TBL] [Abstract][Full Text] [Related]
9. Intussusception and COVID-19 in Children: A Systematic Review and Meta-Analysis. Alhumaid S; Al Alawi Z; Alnaim AA; Al Ghamdi MA; Alabdulqader M; Al Noaim K; Rabaan AA; Al Mutared KM; Al Dossary N; Alsuliman M; Almatawah YA; AlOmran AT; Al HajjiMohammed SM; Alfarhan DR; Al Suwaiq HA; Al Mutarid MM; Alkolib MJ; Mohapatra RK; Al Mutair A Children (Basel); 2022 Nov; 9(11):. PubMed ID: 36421194 [TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis. Alhumaid S; Al Mutair A; Busubaih JS; Al Dossary N; Alsuliman M; Baltyour SA; Alissa I; Al Hassar HI; Al Aithan NA; Albassri HA; AlOmran SA; ALGhazal RM; Busbaih A; Alsalem NA; Alagnam W; Alyousef MY; Alseffay AU; Al Aish HA; Aldiaram A; Al Eissa HA; Alhumaid MA; Bukhamseen AN; Al Mutared KM; Aljwisim AH; Twibah AM; AlSaeed MM; Alkhalaf HA; ALShakhs FM; Koritala T; Al-Tawfiq JA; Dhama K; Rabaan AA; Al-Omari A Infect Agent Cancer; 2022 Sep; 17(1):49. PubMed ID: 36096812 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
13. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Desai AP; Desai AP; Loomis GJ Vaccine; 2021 Jul; 39(32):4407-4409. PubMed ID: 34215453 [TBL] [Abstract][Full Text] [Related]
14. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. ; MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297 [TBL] [Abstract][Full Text] [Related]
16. Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female. Hong A; Sardinas G HCA Healthc J Med; 2022; 3(6):349-354. PubMed ID: 37427315 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations. Wentrys Ł; Stopyra L Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287 [TBL] [Abstract][Full Text] [Related]
18. Gelatin-induced T-cell activation in children with nonanaphylactic-type reactions to vaccines containing gelatin. Taniguchi K; Fujisawa T; Ihara T; Kamiya H J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):1028-32. PubMed ID: 9847445 [TBL] [Abstract][Full Text] [Related]
19. Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis. Guo Y; Cao XS; Yang HT; Zhou MG; Yu B J Glob Health; 2023 Feb; 13():06008. PubMed ID: 36757823 [TBL] [Abstract][Full Text] [Related]